Inhaled medicines: past, present, and future
The purpose of this review is to summarize essential pharmacological, pharmaceutical, and
clinical aspects in the field of orally inhaled therapies that may help scientists seeking to …
clinical aspects in the field of orally inhaled therapies that may help scientists seeking to …
Fungal-bacterial interactions in health and disease
Fungi and bacteria encounter each other in various niches of the human body. There, they
interact directly with one another or indirectly via the host response. In both cases …
interact directly with one another or indirectly via the host response. In both cases …
Nebulised hypertonic saline for cystic fibrosis
Background Hypertonic saline enhances mucociliary clearance and may lessen the
destructive inflammatory process in the airways. This is an update of a previously published …
destructive inflammatory process in the airways. This is an update of a previously published …
Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence
JC Davies - Paediatric respiratory reviews, 2002 - Elsevier
Pseudomonas aeruginosa is the major pathogen in the cystic fibrosis (CF) lung. Prevalence
is high and, once acquired, chronic infection will almost always ensue. Several hypotheses …
is high and, once acquired, chronic infection will almost always ensue. Several hypotheses …
Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial
Rationale Bronchiectasis is characterised by excessive production of mucus and pulmonary
exacerbations. Inhaled osmotic agents may enhance mucociliary clearance, but few long …
exacerbations. Inhaled osmotic agents may enhance mucociliary clearance, but few long …
The CF salt controversy: in vivo observations and therapeutic approaches
There is controversy over whether abnormalities in the salt concentration or volume of
airway surface liquid (ASL) initiate cystic fibrosis (CF) airway disease. In vivo studies of CF …
airway surface liquid (ASL) initiate cystic fibrosis (CF) airway disease. In vivo studies of CF …
Nebulized 3% hypertonic saline solution treatment in hospitalized infants with viral bronchiolitis
A Mandelberg, G Tal, M Witzling, E Someck, S Houri… - Chest, 2003 - Elsevier
Objective: To determine the utility of inhaled hypertonic saline solution to treat infants
hospitalized with viral bronchiolitis. Design: Randomized, double-blind, controlled trial. Fifty …
hospitalized with viral bronchiolitis. Design: Randomized, double-blind, controlled trial. Fifty …
Cough suppressant and pharmacologic protussive therapy: ACCP evidence-based clinical practice guidelines
DC Bolser - Chest, 2006 - Elsevier
Background: Cough-suppressant therapy, previously termed nonspecific antitussive therapy,
incorporates the use of pharmacologic agents with mucolytic effects and/or inhibitory effects …
incorporates the use of pharmacologic agents with mucolytic effects and/or inhibitory effects …
Nebulized 3% hypertonic saline solution treatment in ambulatory children with viral bronchiolitis decreases symptoms
EM Sarrell, G Tal, M Witzling, E Someck, S Houri… - Chest, 2002 - Elsevier
Objective To determine the utility of inhaled hypertonic saline solution to treat ambulatory
infants with viral bronchiolitis. Design Randomized, double-blind, controlled trial. Sixty-five …
infants with viral bronchiolitis. Design Randomized, double-blind, controlled trial. Sixty-five …
[CITAZIONE][C] New concepts of the pathogenesis of cystic fibrosis lung disease
RC Boucher - European Respiratory Journal, 2004 - Eur Respiratory Soc